Stance Capital LLC Novavax Inc Transaction History
Stance Capital LLC
- $161 Billion
- Q4 2024
A detailed history of Stance Capital LLC transactions in Novavax Inc stock. As of the latest transaction made, Stance Capital LLC holds 500 shares of NVAX stock, worth $3,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$3,335% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
287Shares Held
93.2MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$105 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$79 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$74.4 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$51.4 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$38.6 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $522M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...